Filing Details
- Accession Number:
- 0001415889-21-001301
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:01:30
- Reporting Period:
- 2021-03-03
- Accepted Time:
- 2021-03-03 20:01:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591313 | R John Desjarlais | C/O Xencor, Inc. 111 W. Lemon Ave Monrovia CA 91016 | Sr. Vice President & Cso | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-03 | 1,165 | $45.03 | 91,788 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 3,028 restricted stock units.
- The weighted average sale price for the transaction reported was $45.0251, and the range of prices were between $44.92 and $45.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.